U.S. patent application number 13/290249 was filed with the patent office on 2012-03-08 for power injectable port identification.
This patent application is currently assigned to Navilyst Medical, Inc.. Invention is credited to Marcia BUISER, Jeff GRAY.
Application Number | 20120059250 13/290249 |
Document ID | / |
Family ID | 41799874 |
Filed Date | 2012-03-08 |
United States Patent
Application |
20120059250 |
Kind Code |
A1 |
GRAY; Jeff ; et al. |
March 8, 2012 |
Power Injectable Port Identification
Abstract
An implantable port for accessing internal body structures, the
port comprises a proximal housing including an opening providing
access to an interior of the port and a distal housing adapted for
assembly with the proximal housing, the distal housing including a
reservoir which, when the distal housing is mated with the proximal
housing is in fluid communication with the opening of the proximal
housing in combination with a radiopaque element in one of the
proximal and distal housings, a shape of the radiopaque element
identifying, when imaged, a structural characteristic of the port
not otherwise identifiable visually.
Inventors: |
GRAY; Jeff; (Lexington,
MA) ; BUISER; Marcia; (Marlborough, MA) |
Assignee: |
Navilyst Medical, Inc.
Marlborough
MA
|
Family ID: |
41799874 |
Appl. No.: |
13/290249 |
Filed: |
November 7, 2011 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
12207205 |
Sep 9, 2008 |
8075536 |
|
|
13290249 |
|
|
|
|
Current U.S.
Class: |
600/424 |
Current CPC
Class: |
A61M 2039/0238 20130101;
A61M 39/0208 20130101; A61B 6/481 20130101 |
Class at
Publication: |
600/424 |
International
Class: |
A61B 6/00 20060101
A61B006/00 |
Claims
1-21. (canceled)
22. An implantable port, comprising: a wall having a radiopaque
insert integrated therein, wherein the radiopaque insert is
configured to identify an orientation of the port and a
characteristic of the port when exposed to imaging radiation, said
orientation and said characteristic not being clearly visible after
implantation of the port into a living body without the use of
imaging radiation.
23. The implantable port of claim 22, wherein the radiopaque insert
includes a cutout portion allowing imaging radiation to pass
therethrough in a pattern indicative of an orientation or a
characteristic of the port not clearly visible after implantation
into a living body.
24. The implantable port of claim 22, wherein the radiopaque insert
is molded into the wall of the port.
25. The implantable port of claim 22, wherein the port, exclusive
of the radiopaque insert, is formed of a material transparent to
imaging radiation.
26. The implantable port of claim 22, wherein the radiopaque insert
includes titanium.
27. The implantable port of claim 22, wherein a periphery of the
radiopaque insert is shaped to define an identifying mark.
28. The implantable port of claim 22, wherein the radiopaque insert
includes lettering visible when exposed to imaging radiation.
29. The implantable port of claim 22, wherein said characteristic
is one of suitability for power injection and suitability for
contrast-enhanced imaging.
30. An implantable port, comprising: a proximal mateable housing
portion defining a first opening to an interior of the port; a
distal mateable housing portion defining a fluid reservoir capable
of fluid communication with the first opening; and a self-sealing
septum sealing the first opening, wherein a wall of the distal
mateable housing portion includes a radiopaque insert, and wherein
the radiopaque insert is configured to identify an orientation of
the port and a characteristic of the port when exposed to imaging
radiation.
31. The implantable port of claim 30, wherein the proximal and
distal mateable housing portions are formed of a material
transparent to imaging radiation.
32. The implantable port of claim 30, wherein the radiopaque insert
includes titanium.
33. The implantable port of claim 30, wherein the mateable housing
portions are attached to one another using one of an ultrasonic
welding process, a snap-fit mechanism, and a solvent bond.
34. The implantable port of claim 30, wherein the radiopaque insert
includes a cutout portion allowing imaging radiation to pass
therethrough in a pattern indicative of an orientation or a
characteristic of the port not clearly visible after implantation
into a living body.
35. The implantable port of claim 30, wherein the radiopaque insert
is molded into the wall of the distal mateable housing portion.
36. The implantable port of claim 30, wherein a periphery of the
radiopaque insert is shaped to define an identifying mark.
37. The implantable port of claim 30, wherein the radiopaque insert
includes lettering visible when imaged.
38. The implantable port of claim 30, wherein said characteristic
is one of suitability for power injection and suitability for
contrast-enhanced imaging.
39. An implantable port, comprising: proximal and distal mateable
housing portions, the distal mateable housing including at least
one wall defining a fluid reservoir and an underside of the port;
and a radiopaque insert molded into a wall of the distal mateable
housing portion defining the underside of the port, wherein the
radiopaque insert includes at least one of lettering visible when
imaged by exposure to imaging radiation and a cutout portion, and
wherein the radiopaque insert can be imaged to determine an
orientation of the port and a physical characteristic of the port
not clearly visible after implantation into a living body.
40. The implantable port of claim 39, wherein the mateable housing
portions exclusive of the radiopaque insert are formed of a
material transparent to imaging radiation.
41. The implantable port of claim 39, wherein the radiopaque insert
includes titanium.
42. The implantable port of claim 39, wherein a periphery of the
radiopaque insert is shaped to define an identifying mark.
43. The implantable port of claim 39, wherein the radiopaque insert
includes lettering visible when imaged.
44. The implantable port of claim 39, wherein the mateable housing
portions are attached to one another using one of an ultrasonic
welding process, a snap-fit mechanism, and a solvent bond.
45. The implantable port of claim 39, wherein said characteristic
is one of suitability for power injection and suitability for
contrast-enhanced imaging.
Description
BACKGROUND
[0001] Implantable ports are designed for patients who require long
term access to the central venous system or other internal
structures for the administration and/or withdrawal of fluids,
including hydration fluids, antibiotics, chemotherapy, analgesics,
nutritional therapy and blood products. A catheter is typically
inserted to form a path to the vascular system by advancing a
distal end of the catheter into a blood vessel while a proximal end
is connected to the port that is implanted subcutaneously. The port
is generally placed under the skin on the upper part of the chest
wall or the upper arm, and allows patients to access the desired
body lumen while avoiding repeated needlesticks to the target
structure. Power injectable implantable ports offer the additional
advantage of providing access for the power injection of contrast
agents to enhance imaging, such as Contrast-Enhanced Computer
Tomography (CECT) scans, which rely on intravenously administered
contrast agents to enhance the visibility of internal structures.
The contrast agent is power injected into the blood stream to
highlight features that would otherwise be difficult to distinguish
from nearby tissues. Thus, power injectable ports provide access
for the standard injection and withdrawal of fluids (e.g., for
therapeutic purposes) and for power injection of contrast agents to
enhance imaging.
[0002] Although, it is desirable to use ports which are also
suitable for power injection, users must be able to positively
identify such ports to ensure they are not accessing a port which
is not useable for power injection. The industry has established a
"CT" mark, which when viewed under a CT scan, is a standard
indication of power injectability. Some existing "CT" identifying
technologies known in the field today include a cut-through "CT"
design through the port body. The limitation of this design is the
space available on the port that would allow for adequate size and
visibility of the "CT" lettering. Another disadvantage of
cut-through design is that the space could promote tissue ingrowth,
which may make it more difficult to remove the port later.
[0003] Pad printing the "CT" letters onto the port using radiopaque
ink is another existing technology. Radiopaque ink prevents X-rays
or similar radiation waves to pass therethrough so that they may be
identified in scans. However, the radiopaque ink in these ports is
often located on an outer surface of the port, which can be
susceptible to damage such as smearing, cracking and fragmenting in
the subcutaneous environment, making the marking unreadable. In
addition, fragments of ink may migrate, leading to ink integrity
issues.
[0004] Another CT identifying technology is used in the
POWERPORT.RTM., manufactured by Bard Access Systems Inc., Salt Lake
City, Utah. The POWERPORT.RTM. includes an external metal component
with "CT" lettering at the base. However, the "CT" lettering
occupies a space on the base of the port where the device labeling
is typically placed. Device labeling may include manufacturer
and/or lot numbers, which may be helpful in identifying the port.
In addition, there is a risk of the external component becoming
separated from the device.
SUMMARY OF THE INVENTION
[0005] The present invention is directed to an implantable port for
accessing internal body structures, the port comprises a proximal
housing including an opening providing access to an interior of the
port and a distal housing adapted for assembly with the proximal
housing, the distal housing including a reservoir which, when the
distal housing is mated with the proximal housing is in fluid
communication with the opening of the proximal housing in
combination with a radiopaque element in one of the proximal and
distal housings, a shape of the radiopaque element identifying,
when imaged, a structural characteristic of the port not otherwise
identifiable visually.
BRIEF DESCRIPTION OF THE DRAWINGS
[0006] FIG. 1 shows a port according to an exemplary embodiment the
invention;
[0007] FIG. 2 shows a cross-sectional view of a distal housing of
the port of FIG. 1;
[0008] FIG. 3 shows a cross-sectional view of a port according to
another embodiment of the invention;
[0009] FIG. 4 shows an exploded view of the port of FIG. 3;
[0010] FIG. 5 shows an exploded bottom view of a port according to
another embodiment of the invention; and
[0011] FIG. 6 shows an exploded view of a port according to yet
another embodiment of the invention.
DETAILED DESCRIPTION
[0012] The present invention may be further understood with
reference to the following description of exemplary embodiments and
the related appended drawings, wherein like elements are provided
with the same reference numerals. The present invention relates to
devices for accessing the vascular system via a catheter and, more
specifically, relates to a power-injectable port that may be
identified as such after implantation. Those skilled in the art
will understand that the ports described herein are generally
implanted with an opening through which fluids are to be introduced
or withdrawn facing the skin. As used in this application, the term
proximal refers to a direction toward the skin while distal refers
to a distance deeper into the body.
[0013] As shown in FIGS. 1 and 2, a port 10 according to an
exemplary embodiment the invention comprises a distal housing 12
and a proximal housing 14 which are mated together to seal an
internal reservoir 16 coupled to a fluid outlet 18 which is coupled
to a body structure to which fluids are to be supplied and/or from
which fluids are to be withdrawn. A proximal surface of the
proximal housing 14 includes an opening 20 via which fluids are
supplied and/or withdrawn from the reservoir 16. The opening 20 is
sealed by a self-sealing septum 22. Thus, the reservoir and the
body structure to which the outlet 18 is coupled may be accessed by
passing a needle through the septum 22 with the septum 22 resealing
itself as soon as the needle is withdrawn, as would be understood
by those skilled in the art.
[0014] As shown in FIG. 2, a radiopaque insert 24 is embedded in a
base 26 of the distal housing 12. The radiopaque insert 24
incorporates an identifying mark 28 (e.g., a CT mark or other
indication of characteristics of the port) visible through the use
of one or more types of electromagnetic scan such as X-rays, etc.
As would be understood by those skilled in the art, the radiopaque
insert 24 may be formed of any material having the desired
radiopaque properties (e.g., titanium). The identifying mark 28
may, for example, be cut-through the radiopaque insert 24 allowing
the scanning radiation to pass therethrough in a pattern indicative
of a characteristic (e.g., suitability for power injection) of the
port 10. Those skilled in the art will understand that, as the
insert 24 is embedded in the distal housing 12, the cut-through
design of the identifying mark 28 will be clearly visible without
increasing the likelihood of tissue ingrowth. The CT mark shown in
FIG. 2 is for illustrative purposes only, and it will be understood
by those of skill in the art that a CT mark on the radiopaque
insert 24 may be a mirror image of the marking shown so that the CT
may be legible when viewed under the electromagnetic scan.
[0015] As would be understood by those skilled in the art, the
radiopaque insert 24 may be embedded within distal housing 12 via
an insert molding process in which the radiopaque insert 24 is
robotically or hand loaded into a mold cavity between shots. The
insert 24 is supported in position in the mold by a series of
needle-like core pins and, during injection, these pins are
retracted into the mold base as the plastic fills the cavity and
encapsulates the insert. Once the insert 24 has been embedded in
the distal housing 12, the distal housing 12 is ready to be
assembled with the other port components in the same manner for a
port without such a radiopaque insert 24. Standard assembly
techniques such as ultrasonic welding, snap fit or solvent bond may
be utilized as would be understood by those skilled in the art.
[0016] As shown in FIGS. 3 and 4, a port 30 according to another
embodiment of the invention comprises a distal housing 32, a
proximal housing 34 and a radiopaque insert 36. The distal housing
32 includes a distal flange 38 extending radially outward from a
wall of 40 of the distal housing forming a reservoir of the port 30
with a corresponding proximal flange 42 of the proximal housing 34
extending thereover when assembled with the distal housing 32. The
proximal housing 34 is preferably formed so that, when mated with
the distal housing 32, a recess 44 is formed between the distal and
proximal flanges 38, 42, respectively. The radiopaque insert 36 is
received in the recess 44 between the distal and proximal flanges
38, 42, respectively. The distal housing 32 and the proximal
housing 34 may then be joined via any standard plastic joining
process, such as ultrasonic welding, snap-fit, and solvent bond, to
hold the radiopaque insert 36 in place as would be understood by
those skilled in the art.
[0017] As described above, the radiopaque insert 36 may be made of
any radiopaque material with an identifying mark 46 (e.g., CT)
cut-out so that the mark 46 is clearly visible when imaged using
any of the known scanning techniques. As the insert 36 is housed
between the proximal and distal flanges 38, 42, respectively, the
cut-out poses no risk of tissue ingrowth and the risk of the insert
36 becoming detached from the port 30 is also minimized.
[0018] In a further embodiment of the present invention, the
radiopaque insert 36 may be embedded in either of the proximal and
distal flanges 38, 42, respectively using an insert molding
process. As described above, the radiopaque insert 36 may be placed
into a mold cavity between shots and held in place by a series of
needle-like core pins. During injection, these pins are retracted
into the mold base as plastic fills the cavity and encapsulates the
insert 36. Once the insert 36 has been embedded, the distal housing
32 is ready to be assembled with the other port components
including the proximal housing 34 as described above.
[0019] In another embodiment of the present invention, as shown in
FIG. 5, a port 50 comprises a distal housing 52 and a radiopaque
insert 54 having a periphery shaped to define an identifying mark
56. Those skilled in the art will understand that, when the
identifying mark consists of more than one element (e.g., multiple
letters) a minimal amount of radiopaque material may extend between
these elements to maintain a desired alignment during the molding
process. The insert 54 may be overmolded into the distal housing 52
by inserting it into the cavity before injection. The plastic would
form around the insert, leaving the surface of the CT mark visible
on the underside of the base. The distal housing 52 with overmolded
radiopaque insert 54 may be assembled with the rest of the port
components using any standard assembly techniques as described
above.
[0020] In a further embodiment, the overmolded insert 54 may be
mechanically combined with a port stem and inserted into the mold.
Overmolding would then encapsulate and seal the insert . 54 into
the distal housing 52 while simultaneously binding the stem to the
distal housing 52. Such an embodiment provides a radiopaque marker
for power injectability while eliminating a separate stem/port
assembly step.
[0021] In another embodiment of the present invention, shown in
FIG. 6, a port 60 comprises a proximal housing 62 that may be
molded using plastic loaded with radiopaque fillers such as barium,
bismuth, and tungsten. The proximal housing 62 includes a proximal
flange 64 extending radially outward therefrom with a corresponding
distal flange 68 extending radially outward from a distal housing
70 in the same manner described above in regard to the port 30 of
FIGS. 3 and 4. The proximal flange 64 includes an identifying mark
72 mark cut through a thickness thereof (e.g., during a molding
process). The distal housing 70, or at least the distal flange 68,
is formed of standard plastic with no radiopaque fillers so that
the mark 72 creates a "negative" of the mark 72 when imaged (e.g.,
under CT or other body scan). In order to prevent tissue ingrowth,
a silicone boot or skirt may be incorporated such that the boot or
skirt covers the cut-through lettering. It will be understood by
those of skill in the art that the boot or skirt may additionally
be composed of any suitable non-radiopaque material. Furthermore,
those skilled in the art will understand that the distal housing 70
may, alternatively, be formed of a material incorporating
radiopaque fillers with the mark 72 cut out of the distal flange 68
while the proximal housing 64 is formed of a material free of
radiopaque fillers.
[0022] It will be apparent to those skilled in the art that various
modifications and variations can be made in the structure and the
methodology of the present invention, without departing from the
spirit or scope of the invention. Thus, it is intended that the
present invention cover the modifications and variations of this
invention provided that they come within the scope of the appended
claims and their equivalents.
* * * * *